Cash flow Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:38:26 11/03/2026 GMT			5-day change	1st Jan Change
111.00 ^EUR	0.00%		-9.79%	-9.46%

03-09	MERCK KGAA : Goldman Sachs reiterates its Buy rating	ZD
03-09	MERCK KGAA : Deutsche Bank sticks Neutral	ZD

0842b995403f3b36ab5a245fb871.G1Y6g-SjKnwsUDpSG8Gr2w4G7PKcv6iQwquo7YBsqeI.STxbrp3lXhJoPXYQY7WSmmFtiKbK-s7C8fHDu7UY3ZguN1Oxo-5sDl4ccw

Published financial data: MERCK KGAA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	19.69B	22.23B	20.99B	21.16B	21.1B
Total Revenues	19.69B	22.23B	20.99B	21.16B	21.1B
Cost of Goods Sold, Total	7.32B	8.5B	8.56B	8.63B	8.67B
Gross Profit	12.36B	13.74B	12.44B	12.53B	12.43B
Selling General & Admin Expenses, Total	5.47B	5.91B	5.78B	5.79B	5.95B
Stock-Based Compensation (IS)	3M	-7M	2M	11M	-9M
R&D Expenses	2.4B	2.45B	2.44B	2.27B	2.38B
Other Operating Expenses	133M	372M	515M	239M	177M
Other Operating Expenses, Total	8.01B	8.72B	8.74B	8.31B	8.5B
Operating Income	4.35B	5.01B	3.7B	4.21B	3.93B
Interest Expense, Total	-244M	-196M	-260M	-229M	-326M
Interest And Investment Income	46M	71M	172M	164M	93M
Net Interest Expenses	-198M	-125M	-88M	-65M	-233M
Currency Exchange Gains (Loss)	-40M	-109M	51M	48M	196M
Other Non Operating Income (Expenses)	14M	-3M	26M	2M	5M
EBT, Excl. Unusual Items	4.13B	4.78B	3.68B	4.2B	3.9B
Restructuring Charges	-82M	-199M	-248M	-247M	-175M
Merger & Related Restructuring Charges	-119M	-83M	-	-25M	-122M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	63M	54M	132M	-3M	157M
Asset Writedown	-54M	-232M	-98M	-328M	-418M
Legal Settlements	8M	-6M	-1M	-48M	-54M
Other Unusual Items	-21M	-23M	15M	-11M	22M
EBT, Incl. Unusual Items	3.92B	4.29B	3.48B	3.54B	3.31B
Income Tax Expense	859M	948M	650M	751M	693M
Earnings From Continuing Operations	3.06B	3.34B	2.83B	2.79B	2.62B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	3.06B	3.34B	2.83B	2.79B	2.62B
Minority Interest	-10M	-14M	-10M	-9M	-7M
Net Income - (IS)	3.06B	3.33B	2.82B	2.78B	2.61B
Net Income to Common Incl Extra Items	3.06B	3.33B	2.82B	2.78B	2.61B
Net Income to Common Excl. Extra Items	3.06B	3.33B	2.82B	2.78B	2.61B
Per Share Items
Net EPS - Basic	7.03	7.65	6.5	6.39	6
Basic EPS - Continuing Operations	7.03	7.65	6.5	6.39	6
Basic Weighted Average Shares Outstanding	435M	435M	435M	435M	435M
Net EPS - Diluted	7.03	7.65	6.49	6.39	6
Diluted EPS - Continuing Operations	7.03	7.65	6.49	6.39	6
Diluted Weighted Average Shares Outstanding	435M	435M	435M	435M	435M
Normalized Basic EPS	5.91	6.83	5.27	6.02	5.59
Normalized Diluted EPS	5.91	6.83	5.27	6.02	5.59
Dividend Per Share	1.85	2.2	2.2	2.2	2.2
Payout Ratio	24.48	28.71	40.79	37.13	39.84
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	5.83B	6.56B	5.23B	5.91B	5.7B
EBITA	5.16B	5.84B	4.48B	4.93B	4.7B
EBIT	4.35B	5.01B	3.7B	4.21B	3.93B
EBITDAR	5.85B	6.57B	5.24B	5.92B	5.71B
Effective Tax Rate - (Ratio)	21.89	22.11	18.66	21.23	20.95
Total Current Taxes	1.08B	1.34B	1.14B	1.15B	1.13B
Total Deferred Taxes	-174M	-369M	-323M	-257M	-437M
Normalized Net Income	2.57B	2.97B	2.29B	2.62B	2.43B
Interest Capitalized	11M	17M	22M	38M	42M
Interest on Long-Term Debt	10M	13M	14M	25M	28M
Non-Cash Pension Expense	28M	44M	59M	64M	59M
Supplemental Operating Expense Items
Advertising Expense	461M	476M	515M	526M	556M
Selling and Marketing Expenses	4.29B	4.68B	4.47B	4.51B	4.5B
General and Administrative Expenses	1.16B	1.19B	1.26B	1.22B	1.39B
Research And Development Expense From Footnotes	2.41B	2.52B	2.44B	2.28B	2.42B
Net Rental Expense, Total	18M	14M	11M	8M	7M
Imputed Operating Lease Interest Expense	3.2M	2.25M	2.44M	1.69M	1.85M
Imputed Operating Lease Depreciation	14.8M	11.75M	8.56M	6.31M	5.15M
Stock-Based Comp., Other (Total)	3M	-7M	2M	11M	-9M
Total Stock-Based Compensation	3M	-7M	2M	11M	-9M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.9B	1.85B	1.98B	2.52B	2.74B
Short Term Investments	100M	203M	398M	558M	597M
Trading Asset Securities, Total	12M	42M	33M	-	-
Total Cash And Short Term Investments	2.01B	2.1B	2.41B	3.08B	3.34B
Accounts Receivable, Total	3.72B	4.13B	3.98B	3.95B	3.88B
Other Receivables	1.05B	900M	928M	945M	888M
Notes Receivable	-	-	1M	1M	-
Total Receivables	4.77B	5.03B	4.9B	4.9B	4.77B
Inventory	3.9B	4.63B	4.64B	4.48B	4.56B
Prepaid Expenses	142M	210M	182M	169M	182M
Other Current Assets, Total	157M	226M	256M	822M	379M
Total Current Assets	10.98B	12.2B	12.39B	13.45B	13.23B
Gross Property Plant And Equipment	14.81B	16.51B	17.94B	19.11B	19.54B
Accumulated Depreciation	-7.59B	-8.31B	-8.89B	-9.09B	-9.6B
Net Property Plant And Equipment	7.22B	8.2B	9.06B	10.02B	9.94B
Long-term Investments	615M	675M	808M	964M	772M
Goodwill	17B	18.42B	17.84B	19.15B	17.93B
Other Intangibles, Total	7.61B	7.3B	6.55B	6.28B	7.66B
Accounts Receivable Long-Term	-	-	-	-	-
Loans Receivable Long-Term	4M	4M	4M	3M	4M
Deferred Tax Assets Long-Term	1.5B	1.31B	1.51B	1.31B	1.62B
Other Long-Term Assets, Total	426M	416M	324M	381M	369M
Total Assets	45.36B	48.53B	48.5B	51.57B	51.53B
Liabilities
Accounts Payable, Total	1.54B	1.6B	1.77B	1.5B	1.42B
Accrued Expenses, Total	1.56B	1.53B	1.49B	1.63B	1.64B
Short-term Borrowings	896M	-	-	-	-
Current Portion of Long-Term Debt	1.52B	1.1B	580M	3.17B	1.12B
Current Portion of Leases	117M	125M	122M	137M	123M
Current Income Taxes Payable	1.42B	1.48B	1.43B	1.53B	1.58B
Unearned Revenue Current, Total	198M	282M	249M	203M	216M
Other Current Liabilities	3.18B	3.4B	3.06B	3.12B	2.94B
Total Current Liabilities	10.43B	9.51B	8.7B	11.29B	9.04B
Long-Term Debt	7.93B	8.83B	8.85B	6.37B	10.2B
Long-Term Leases	342M	366M	393M	625M	525M
Unearned Revenue Non Current	3M	3M	3M	3M	2M
Pension & Other Post Retirement Benefits	3.4B	2.03B	2.19B	1.96B	1.55B
Deferred Tax Liability Non Current	1.41B	1.28B	1.13B	892M	1.13B
Other Non Current Liabilities	428M	496M	477M	438M	406M
Total Liabilities	23.95B	22.52B	21.74B	21.58B	22.87B
Common Stock, Total	565M	565M	565M	565M	565M
Additional Paid In Capital	3.81B	3.81B	3.81B	3.81B	3.81B
Retained Earnings	16.61B	18.81B	20.63B	22.42B	24.02B
Comprehensive Income and Other	349M	2.74B	1.67B	3.11B	198M
Total Common Equity	21.34B	25.93B	26.68B	29.91B	28.59B
Minority Interest	78M	78M	75M	75M	68M
Total Equity	21.42B	26B	26.76B	29.99B	28.66B
Total Liabilities And Equity	45.36B	48.53B	48.5B	51.57B	51.53B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	435M	435M	435M	435M	435M
ECS Total Common Shares Outstanding	435M	435M	435M	435M	435M
Book Value / Share	49.08	59.63	61.36	68.8	65.76
Tangible Book Value	-3.28B	210M	2.28B	4.48B	3B
Tangible Book Value Per Share	-7.54	0.48	5.25	10.3	6.9
Total Debt	10.8B	10.43B	9.94B	10.3B	11.97B
Net Debt	8.79B	8.33B	7.53B	7.23B	8.63B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.97B	1.63B	1.92B	1.63B	1.22B
Debt Equivalent Oper. Leases	144M	112M	88M	64M	56M
Minority Interest, Total (Incl. Fin. Div)	78M	78M	75M	75M	68M
Equity Method Investments, Total	3M	3M	3M	3M	3M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	814M	1.08B	1.16B	1.02B	1B
Inventories - Work In Process, Total	990M	1.42B	1.43B	1.46B	1.59B
Inventories - Finished Goods, Total	2.1B	2.14B	2.04B	2B	1.96B
Land - (BS)	5.46B	5.98B	6.33B	7.48B	7.36B
Machinery, Total	5.69B	6.23B	6.63B	7.08B	7.4B
Full Time Employees	60.33K	64.23K	62.91K	59.02K	59.08K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	59M	63M	97M	101M	73M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	3.06B	3.33B	2.82B	2.78B	2.61B
Depreciation & Amortization - CF	814M	866M	895M	982M	1B
Amortization of Goodwill and Intangible Assets - (CF)	803M	830M	783M	714M	770M
Depreciation & Amortization, Total	1.62B	1.7B	1.68B	1.7B	1.77B
Amortization of Deferred Charges, Total - (CF)	90M	102M	104M	110M	109M
(Gain) Loss From Sale Of Asset	-24M	-48M	-150M	-2M	-164M
Asset Writedown & Restructuring Costs	55M	232M	98M	328M	419M
Other Operating Activities, Total	97M	33M	-63M	-13M	4M
Change In Accounts Receivable	-310M	-413M	-8M	79M	-166M
Change In Inventories	-472M	-604M	-89M	36M	-257M
Change In Accounts Payable	433M	101M	-43M	-178M	73M
Change in Other Net Operating Assets	75M	-166M	-567M	-247M	-464M
Cash from Operations	4.62B	4.26B	3.78B	4.59B	3.93B
Capital Expenditure	-1.07B	-1.53B	-1.81B	-1.7B	-1.58B
Sale of Property, Plant, and Equipment	7M	21M	19M	27M	25M
Cash Acquisitions	-4M	-854M	-12M	-774M	-2.92B
Divestitures	1M	4M	-	7M	415M
Sale (Purchase) of Intangible assets	-316M	-237M	-80M	-464M	-202M
Investment in Marketable and Equity Securities, Total	-200M	-145M	-27M	-	-
Other Investing Activities, Total	-	-1M	15M	-144M	1M
Cash from Investing	-1.58B	-2.74B	-1.89B	-3.05B	-4.26B
Short Term Debt Issued, Total	471M	-	-	683M	809M
Long-Term Debt Issued, Total	388M	3.91B	1.22B	2.11B	9.05B
Total Debt Issued	859M	3.91B	1.22B	2.8B	9.86B
Short Term Debt Repaid, Total	-393M	-1.61B	-420M	-453M	-247M
Long-Term Debt Repaid, Total	-2.21B	-2.89B	-1.36B	-2.29B	-7.94B
Total Debt Repaid	-2.61B	-4.5B	-1.78B	-2.74B	-8.18B
Common Dividends Paid	-748M	-955M	-1.15B	-1.03B	-1.04B
Common & Preferred Stock Dividends Paid	-748M	-955M	-1.15B	-1.03B	-1.04B
Other Financing Activities, Total	-9M	-12M	-12M	-7M	-10M
Cash from Financing	-2.5B	-1.56B	-1.73B	-985M	628M
Foreign Exchange Rate Adjustments	9M	-7M	-31M	-16M	-77M
Miscellaneous Cash Flow Adjustments	-	1M	-1M	-	1M
Net Change in Cash	543M	-45M	128M	535M	223M
Supplemental Items
Cash Interest Paid	216M	185M	181M	240M	296M
Cash Income Tax Paid (Refund)	1.04B	1.2B	1.02B	957M	939M
Levered Free Cash Flow	2.86B	2.29B	1.88B	1.74B	2.63B
Unlevered Free Cash Flow	3.02B	2.41B	2.04B	1.88B	2.83B
Change In Net Working Capital	32M	747M	167M	402M	-294M
Net Debt Issued / Repaid	-1.75B	-588M	-568M	53M	1.68B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.24	6.68	4.76	5.26	4.76
Return on Total Capital	8.87	9.13	6.32	6.84	6.07
Return On Equity %	15.95	14.09	10.74	9.82	8.92
Return on Common Equity	15.96	14.07	10.74	9.81	8.92
Margin Analysis
Gross Profit Margin %	62.79	61.79	59.23	59.21	58.9
SG&A Margin	27.8	26.59	27.55	27.39	28.18
EBITDA Margin %	29.61	29.5	24.89	27.94	27.01
EBITA Margin %	26.19	26.29	21.33	23.29	22.27
EBIT Margin %	22.11	22.55	17.6	19.92	18.62
Income From Continuing Operations Margin %	15.57	15.02	13.5	13.17	12.39
Net Income Margin %	15.52	14.96	13.45	13.13	12.36
Net Avail. For Common Margin %	15.52	14.96	13.45	13.13	12.36
Normalized Net Income Margin	13.06	13.37	10.92	12.36	11.51
Levered Free Cash Flow Margin	14.55	10.29	8.94	8.22	12.46
Unlevered Free Cash Flow Margin	15.32	10.84	9.71	8.9	13.43
Asset Turnover
Asset Turnover	0.45	0.47	0.43	0.42	0.41
Fixed Assets Turnover	2.89	2.88	2.43	2.22	2.11
Receivables Turnover (Average Receivables)	5.67	5.66	5.18	5.34	5.39
Inventory Turnover (Average Inventory)	2.04	1.99	1.85	1.89	1.92
Short Term Liquidity
Current Ratio	1.05	1.28	1.42	1.19	1.46
Quick Ratio	0.65	0.75	0.84	0.71	0.9
Operating Cash Flow to Current Liabilities	0.44	0.45	0.43	0.41	0.43
Days Sales Outstanding (Average Receivables)	64.38	64.51	70.5	68.59	67.77
Days Outstanding Inventory (Average Inventory)	179.24	183.29	197.66	193.41	190.35
Average Days Payable Outstanding	60.68	62.05	71.74	70.64	60.98
Cash Conversion Cycle (Average Days)	182.94	185.75	196.43	191.37	197.14
Long Term Solvency
Total Debt/Equity	50.43	40.1	37.16	34.35	41.76
Total Debt / Total Capital	33.53	28.62	27.09	25.57	29.46
LT Debt/Equity	38.62	35.38	34.53	23.33	37.44
Long-Term Debt / Total Capital	25.67	25.25	25.18	17.37	26.41
Total Liabilities / Total Assets	52.79	46.41	44.83	41.85	44.38
EBIT / Interest Expense	17.84	25.58	14.21	18.4	12.06
EBITDA / Interest Expense	24.47	34.23	20.67	25.81	17.48
(EBITDA - Capex) / Interest Expense	20.1	26.42	13.72	18.38	12.62
Total Debt / EBITDA	1.81	1.55	1.85	1.74	2.1
Net Debt / EBITDA	1.47	1.24	1.4	1.22	1.51
Total Debt / (EBITDA - Capex)	2.2	2.01	2.79	2.45	2.91
Net Debt / (EBITDA - Capex)	1.79	1.61	2.11	1.72	2.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.28	12.93	-5.57	0.78	-0.26
Gross Profit, 1 Yr. Growth %	14.97	11.12	-9.45	0.72	-0.77
EBITDA, 1 Yr. Growth %	26.99	13.3	-19.87	7.18	-3.49
EBITA, 1 Yr. Growth %	31.23	14.39	-22.9	6.69	-4.55
EBIT, 1 Yr. Growth %	41.75	16.44	-25.77	9.85	-6.65
Earnings From Cont. Operations, 1 Yr. Growth %	53.71	8.97	-15.15	-1.69	-6.14
Net Income, 1 Yr. Growth %	53.75	8.87	-15.09	-1.66	-6.09
Normalized Net Income, 1 Yr. Growth %	51.61	16.79	-22.27	9.86	-7.12
Diluted EPS Before Extra, 1 Yr. Growth %	53.75	8.87	-15.16	-1.58	-6.09
Accounts Receivable, 1 Yr. Growth %	15.62	11.01	-3.82	-0.55	-1.82
Inventory, 1 Yr. Growth %	18.4	18.77	0.11	-3.3	1.74
Net Property, Plant and Equip., 1 Yr. Growth %	12.4	13.66	10.39	10.7	-0.85
Total Assets, 1 Yr. Growth %	8.53	6.98	-0.08	6.33	-0.13
Tangible Book Value, 1 Yr. Growth %	-50.83	-106.41	1.03K	96.15	-32.75
Common Equity, 1 Yr. Growth %	25.92	21.51	2.9	12.11	-4.42
Cash From Operations, 1 Yr. Growth %	32.76	-7.73	-11.15	21.19	-14.26
Capital Expenditures, 1 Yr. Growth %	-24.56	43.62	18.03	-5.81	-6.87
Levered Free Cash Flow, 1 Yr. Growth %	53.79	-19.44	-17.16	-11.47	51.2
Unlevered Free Cash Flow, 1 Yr. Growth %	45.92	-19.47	-14.61	-11.5	50.52
Dividend Per Share, 1 Yr. Growth %	32.14	18.92	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.4	12.6	3.26	-2.45	0.26
Gross Profit, 2 Yr. CAGR %	10.08	13.03	0.29	-4.49	-0.03
EBITDA, 2 Yr. CAGR %	17.34	19.52	-4.98	-4.81	1.67
EBITA, 2 Yr. CAGR %	18.48	21.96	-6.38	-7.89	0.87
EBIT, 2 Yr. CAGR %	30.58	27.78	-7.37	-7.99	1.22
Earnings From Cont. Operations, 2 Yr. CAGR %	53.84	29.42	-3.84	-8.67	-3.94
Net Income, 2 Yr. CAGR %	52.13	29.38	-3.86	-8.63	-3.9
Normalized Net Income, 2 Yr. CAGR %	39.15	32.39	-5.08	-5.83	1.02
Diluted EPS Before Extra, 2 Yr. CAGR %	53.81	29.38	-3.89	-8.63	-3.86
Accounts Receivable, 2 Yr. CAGR %	6.13	13.29	3.33	-2.2	-1.19
Inventory, 2 Yr. CAGR %	8.03	18.58	9.04	-1.61	-0.81
Net Property, Plant and Equip., 2 Yr. CAGR %	7.96	13.03	12.02	10.54	4.77
Total Assets, 2 Yr. CAGR %	1.76	7.75	3.4	3.08	3.08
Tangible Book Value, 2 Yr. CAGR %	-37.88	-82.25	-16.53	369.78	14.57
Common Equity, 2 Yr. CAGR %	9.36	23.69	11.82	7.41	3.52
Cash From Operations, 2 Yr. CAGR %	27.13	10.68	-9.46	3.77	1.94
Capital Expenditures, 2 Yr. CAGR %	14.51	4.09	30.2	5.44	-6.34
Levered Free Cash Flow, 2 Yr. CAGR %	16.9	10.82	-18.69	-12.38	15.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.36	7.96	-17.44	-11.21	15.4
Dividend Per Share, 2 Yr. CAGR %	19.29	25.36	9.05	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.89	11.24	6.19	2.43	-1.72
Gross Profit, 3 Yr. CAGR %	9.2	10.43	4.97	0.44	-3.27
EBITDA, 3 Yr. CAGR %	16.63	15.7	4.41	0.7	-4.39
EBITA, 3 Yr. CAGR %	17.83	16.74	4.46	-1.2	-6.81
EBIT, 3 Yr. CAGR %	30.07	25.23	6.36	-0.72	-7.58
Earnings From Cont. Operations, 3 Yr. CAGR %	41.02	37.14	12.43	-3.13	-7.83
Net Income, 3 Yr. CAGR %	-3.26	36.08	12.43	-3.13	-7.79
Normalized Net Income, 3 Yr. CAGR %	34.62	30.81	10.58	0.92	-6.26
Diluted EPS Before Extra, 3 Yr. CAGR %	41.82	37.08	12.4	-3.13	-7.79
Accounts Receivable, 3 Yr. CAGR %	7.93	7.73	7.27	2.02	-2.07
Inventory, 3 Yr. CAGR %	12.16	11.49	12.07	4.76	-0.51
Net Property, Plant and Equip., 3 Yr. CAGR %	14.47	9.83	12.14	11.58	6.61
Total Assets, 3 Yr. CAGR %	7.14	3.47	5.08	4.37	2.01
Tangible Book Value, 3 Yr. CAGR %	-4.81	-70.87	-30.02	10.97	145.35
Common Equity, 3 Yr. CAGR %	7.45	13.27	16.33	11.92	3.32
Cash From Operations, 3 Yr. CAGR %	27.65	14.25	2.86	-0.22	-2.63
Capital Expenditures, 3 Yr. CAGR %	5.42	23.49	8.54	16.88	1.16
Levered Free Cash Flow, 3 Yr. CAGR %	10.29	2.96	0.26	-15.06	5.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.43	0.87	-0.45	-14.31	5.86
Dividend Per Share, 3 Yr. CAGR %	13.96	19.17	16.26	5.95	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.56	8.9	7.19	5.55	3.77
Gross Profit, 5 Yr. CAGR %	4.71	7.7	5.55	4.19	2.94
EBITDA, 5 Yr. CAGR %	6.76	8.35	7.3	6.9	4.42
EBITA, 5 Yr. CAGR %	7.01	8.64	7.28	6.05	3.65
EBIT, 5 Yr. CAGR %	12.12	13.52	13.31	10.54	5.06
Earnings From Cont. Operations, 5 Yr. CAGR %	13.42	5.48	20.99	16.56	5.57
Net Income, 5 Yr. CAGR %	13.4	5.01	-3.5	16.04	5.59
Normalized Net Income, 5 Yr. CAGR %	14.2	14.66	16.82	14.52	7.46
Diluted EPS Before Extra, 5 Yr. CAGR %	13.38	5.48	21.38	16.55	5.59
Accounts Receivable, 5 Yr. CAGR %	5.21	7.18	6.06	3.64	3.8
Inventory, 5 Yr. CAGR %	8.37	11.97	10.9	6.06	6.73
Net Property, Plant and Equip., 5 Yr. CAGR %	11.27	12.7	13.49	10.12	9.13
Total Assets, 5 Yr. CAGR %	3.47	6.38	5.62	3.32	4.28
Tangible Book Value, 5 Yr. CAGR %	-21.51	-51.59	-9.69	-12.01	-14.77
Common Equity, 5 Yr. CAGR %	8.81	13.11	9.18	10.89	11.03
Cash From Operations, 5 Yr. CAGR %	12.89	9.58	11.26	9.93	2.49
Capital Expenditures, 5 Yr. CAGR %	8.29	10.75	14.71	15.92	2.32
Levered Free Cash Flow, 5 Yr. CAGR %	4.36	-0.47	-2.54	-3.66	7.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.87	-0.94	-2.4	-4.32	6.51
Dividend Per Share, 5 Yr. CAGR %	9.04	11.97	11.97	11.1	9.46